Chuck Schumer urges FDA and drug manufacturers to expedite RSV vaccine production.

Senator Chuck Schumer is urging the FDA and drug manufacturers to expedite the production of the RSV vaccine, Beyfortus, due to nationwide shortages. The vaccine, which reduces the risk of severe infection by up to 75%, is recommended for infants younger than eight months but has experienced a shortage in supply. Schumer proposes increased distribution of vaccine doses from the CDC and prioritizing Beyfortus manufacturers in the FDA's supply chain.

February 19, 2024
4 Articles